share_log

Pharming Q3 EPS $(0.002) Misses $0.01 Estimate, Sales $74.80M Miss $76.93M Estimate

Benzinga ·  Oct 24, 2024 13:40

Pharming (NASDAQ:PHAR) reported quarterly losses of $(0.00) per share which missed the analyst consensus estimate of $0.01 by 120 percent. This is a 140 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $74.80 million which missed the analyst consensus estimate of $76.93 million by 2.77 percent. This is a 12.14 percent increase over sales of $66.70 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment